covid
Buscar en
Revista Española de Nutrición Humana y Dietética
Toda la web
Inicio Revista Española de Nutrición Humana y Dietética Manifestaciones cutáneas en la obesidad
Información de la revista
Vol. 15. Núm. 2.
Páginas 56-61 (abril - junio 2011)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 15. Núm. 2.
Páginas 56-61 (abril - junio 2011)
Revisión
Acceso a texto completo
Manifestaciones cutáneas en la obesidad
Cutaneous manifestations in obesity
Visitas
7300
José Alfredo Martínez-Hernándeza,
Autor para correspondencia
jalfmtz@unav.es

Autor para correspondencia.
, Diego Martínez-Urbistondob, Francisco José Carapeto Márquez de Pradoc
a Departamento de Fisiología y Nutrición, Universidad de Navarra, Pamplona, Navarra, España
b Servicio de Dermatología, Hospital Clínico, Universidad de Zaragoza, Zaragoza, España
c Servicio de Medicina Interna, Clínica Universitaria de Navarra, Pamplona, Navarra, España
Este artículo ha recibido
Información del artículo
Resumen

La obesidad supone un problema de salud pública cuya creciente prevalencia es atribuida en gran medida a interacciones entre inadecuados hábitos dietéticos y sedentarismo colectivo con cierta predisposición genética. La acumulación crónica de grasa en el tejido adiposo, propia de la obesidad, se asocia a una serie de complicaciones clínicas como la diabetes, las enfermedades cardiovasculares, la hipercolesterolemia, etc. También, manifestaciones cutáneas y dermatosis pueden hallarse en pacientes obesos, incluyendo: acantosis nigricans y excrecencias/papilomas (debido a resistencia de insulina); hiperandrogenismo; estrías debidas a sobreextensión; adiposis, hiperpigmentación; linfedema; celulitis, intertrigo y dermatitis perineal; hiperqueratosis pilar y plantar con cambios morfológicos de la anatomía del pie y determinadas complicaciones que pueden provenir de la hospitalización, como úlceras de presión, una cicatrización disminuida e incontinencia, cuyo cuidado debe ser meticuloso con énfasis en la prevención cuando sea posible. El reconocimiento y el control de las complicaciones dermatológicas de la obesidad pueden tener un papel importante en la disminución de la morbosidad de obesidad.

Palabras clave:
Piel
Sobrepeso
Dermatosis
Obesidad
Abstract

Obesity is a worldwide public health problem with an increasing prevalence mainly attributed to interactions between an inadequate diet and sedentary habits and the individual's genetic predisposition. A chronic accumulation of adipose tissue found in obesity is associated to a myriad of complications such as diabetes, cardiovascular diseases, hypercholesterolemia, etc. Also, dermatological changes have been reported in patients with obesity, including: acanthosis nigricans and skin tags/acrocordons (due to insulin resistance); hyperandrogenism; striae; adiposis dolorosa, hyperpigmentation; lymphedema; cellulitis, intertrigo and perineal dermatitis; hyperkeratosis pilaris and plantaris with morphological changes. Complications that may arise from hospitalisation such as pressure ulcers, diminished wound healing and incontinence, must all be carefully managed with an emphasis on prevention where possible. Recognition and control of the dermatological complications of obesity play an important role in decreasing the morbidity of obesity.

Keywords:
Skin
Overweightness
Dermatoses
Obesity
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.A. Martínez.
Genomic medicine and obesity.
Genomic and personalized medicine, pp. 1170-1179
[2.]
J. Galgani, E. Ravussin.
Energy metabolism, fuel selection and body weight regulation.
Int J Obes (Lond), 32 (2008), pp. S109-S119
[3.]
A. Marti, J.A. Martinez.
Genetics of obesity: gene x nutrient interactions.
Int J Vitam Nutr Res, 76 (2006), pp. 184-193
[4.]
T. Steemburgo, M.J. De Azevedo, J.A. Martínez.
Gene-nutrient interaction and its association with obesity and diabetes mellitus.
Arq Bras Endocrinol Metabol, 53 (2009), pp. 497-508
[5.]
J. Salas-Salvadó, M.A. Rubio, M. Barbany, B. Moreno, SEEDO 2007.
[Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria].
Med Clin (Barc), 128 (2007), pp. 184-196
[6.]
World Health Organization. Obesity and overweight [citado Jul 2010). Disponible en: www.Whoint/mediacentre/factssheets311/en/index.html
[7.]
Monereo S, Molina B. Costes socioeconómicos de la obesidad. Monografía Humanitas (Ed. Xformiguera). Barcelona; 2006.
[8.]
J.A. Martinez.
Body-weight regulation: causes of obesity.
Proc Nutr Soc, 59 (2000), pp. 337-345
[9.]
M. Hernández, S. Pérez, B. Martínez de Morentin, S. Navas, J.A. Martínez.
Estudio comparativo de medidas de composición corporal por absorciometría, bioimpedencia y pliegues cutáneos.
An Real Acad Farmacia, 76 (2011), pp. 209-222
[10.]
A. Marti, M.A. Martinez-González, J.A. Martinez.
Interaction between genes and lifestyle factors on obesity.
Proc Nutr Soc, 67 (2008), pp. 1-8
[11.]
J. Campión, F.I. Milagro, J.A. Martínez.
Individuality and epigenetics in obesity.
[12.]
A. Marti, M.J. Moreno-Aliaga, J. Hebebrand, J.A. Martínez.
Genes, lifestyles and obesity.
Int J Obes Relat Metab Disord, 28 (2004), pp. S29-S36
[13.]
W. Krause.
Dermatoses in obesity: sick skin over the adipose tissue.
MMW Fortschr Med, 150 (2008), pp. 45-47
[14.]
J.M. Lecerf, C. Reitz, A. De Chasteigner.
Evaluation of discomfort and complications in a population of 18,102 patients overweight or obese patients.
Presse Med, 32 (2003), pp. 689-695
[15.]
N.S. Sheinfeld, D.H. Parish, L.C. Parish.
A primer of skin diseases associated with obesity.
Expert Review of Dermatology, 2 (2007), pp. 409-415
[16.]
G. Yosipovitch, A. DeVore, A. Daen.
Obesity and the skin: skin physiology and skin manifestations of obesity.
J Am Acad Dermatol, 56 (2007), pp. 901-916
[17.]
E. Wenczl.
Skin manifestations, treatment and rehabilitation in overweight and obesity.
Orv Hetil, 150 (2009), pp. 1731-1738
[18.]
B. Guida, M. Nino, N.R. Perrino, R. Lacceti, R. Trio, S. Labella, et al.
The impact of obesity on skin disease and epidermal permeability barrier status.
[19.]
N.S. Scheinfeld.
Obesity and dermatology.
Clin Dermatol, 22 (2004), pp. 303-309
[20.]
B. Hahler.
An overview of dermatological conditions commonly associated with the obese patient.
Ostomy Wound Manage, 52 (2006), pp. 34-36
[21.]
P. Quatresooz, L. Thirion, C. Piérard-Franchimont, G. Szepetiuk, H. Valdes, A. Beckers, et al.
Cutaneous signs of endocrinopathies.
Rev Med Liege, 61 (2006), pp. 104-108
[22.]
T. Kasai, M. Hirose, T. Matsukawa, A. Takamata, Y. Tanaka.
The vasoconstriction threshold is increased in obese patients during general anaesthesia.
Acta Anaesthesiol Scand, 47 (2003), pp. 588-592
[23.]
B. Markoff, A. Amsterdam.
Impact of obesity on hospitalized patients.
Mt Sinai J Med, 75 (2008), pp. 454-459
[24.]
O. Lamas, A. Marti, J.A. Martínez.
Obesity and immunocompetence.
Eur J Clin Nutr, 56 (2002), pp. S42-S45
[25.]
H. Löffler, J.U. Aramaki, I. Effendy.
The influence of body mass index on skin susceptibility to sodium lauryl sulphate.
Skin Res Technol, 8 (2002), pp. 19-22
[26.]
W.H. Goodson 3rd, T.K. Hunt.
Wound collagen accumulation in obese hyperglycemic mice.
Diabetes, 35 (1986), pp. 491-495
[27.]
B. Stallmeyer, J. Pfeilschifter, S. Frank.
Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice.
Diabetologia, 44 (2001), pp. 471-479
[28.]
L. García Hidalgo.
Dermatological complications of obesity.
Am J Acad Dermat, 3 (2002), pp. 497-506
[29.]
M.A. Zulet, B. Puchau, C. Navarro, A. Martí, J.A. Martínez.
Inflammatory biomarkers: the link between obesity and associated pathologies.
Nutr Hosp, 22 (2007), pp. 511-527
[30.]
O. Martalo, C. Piérard-Franchimont, A. Scheen, G.E. Piérard.
[Skin diseases and obesity].
Rev Med Liege, 58 (2003), pp. 73-76
[31.]
S.A. Jabbour.
Cutaneous manifestations of endocrine disorders: a guide for dermatologists.
Am J Clin Dermatol, 4 (2003), pp. 315-331
[32.]
A. Romo, S. Benavides.
Treatment options in insulin resistance obesity-related acanthosis nigricans.
Ann Pharmacother, 42 (2008), pp. 1090-1094
[33.]
A.S. Katz, D.C. Goff, S.R. Feldman.
Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease.
Dermatol Online J, 6 (2000), pp. 1
[34.]
G. Sadeghian, H. Ziaie, M. Amini, M. Ali Nilfroushzadeh.
Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
J Dermatol, 36 (2009), pp. 209-212
[35.]
T. Hermanns-Lê, A. Scheen, G.E. Piérard.
Acanthosis nigricans associated with insulin resistance: pathophysiology and management.
Am J Clin Dermatol, 5 (2004), pp. 199-203
[36.]
D. Light, G.M. Arvanitis, D. Abramson, S.B. Glasberg.
Effect of weight loss after bariatric surgery on skin and the extracellular matrix.
Plast Reconstr Surg, 125 (2010), pp. 343-351
[37.]
D. Glintborg, M. Andersen.
An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome.
Gynecol Endocrinol, 26 (2010), pp. 281-296
[38.]
L. García-Hidalgo, R. Orozco-Topete, J. Gonzalez-Barranco, A.R. Villa, J.J. Dalman, G. Ortiz-Pedroza.
Dermatoses in 156 obese adults.
Obes Res, 7 (1999), pp. 299-302
[39.]
C.K. Janniger, R.A. Schwartz, J.C. Szepietowski, A. Reich.
Intertrigo and common secondary skin infections.
Am Fam Physician, 72 (2005), pp. 833-838
[40.]
M. Manduch, A.M. Oliveira, A.G. Nascimento, A.L. Folpe.
Massive localised lymphoedema: a clinicopathological study of 22 cases and review of the literature.
J Clin Pathol, 62 (2009), pp. 808-811
[41.]
S. Lu, T.A. Tran, D.M. Jones, D.R. Meyer, J.S. Ross, H.A. Fisher, et al.
Localized lymphedema (elephantiasis): a case series and review of the literature.
J Cutan Pathol, 36 (2009), pp. 1-20
[42.]
M.H. Khan, F. Victor, B. Rao, N.S. Sadick.
Treatment of cellulite: Part I. Pathophysiology.
J Am Acad Dermatol, 62 (2010), pp. 361-370
[43.]
J.W. McGowan, D.J. Pearce, J. Chen, D. Richmond, R. Balkrishnan, S.R. Feldman.
The skinny on psoriasis and obesity.
Arch Dermatol, 141 (2005), pp. 1601-1602
[44.]
L. Naldi, L. Chatenoud, D. Linder, A. Belloni Fortina, A. Peserico, A.R. Virgili, et al.
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.
J Invest Dermatol, 125 (2005), pp. 61-67
[45.]
S. Gallagher, J. Gates.
Challenges of ostomy care and obesity.
Ostomy Wound Manage, 50 (2004), pp. 38-40
[46.]
S.M. Gallagher.
Morbid obesity: a chronic disease with an impact on wounds and related problems.
Ostomy Wound Manage, 43 (1997), pp. 18-24
[47.]
C.J. Mathison.
Skin and wound care challenges in the hospitalized morbidly obese patient.
J Wound Ostomy Continence Nurs, 30 (2003), pp. 78-83
[48.]
S. Guo, L.A. Dipietro.
Factors affecting wound healing.
J Dent Res, 89 (2010), pp. 219-229
[49.]
B.B. Davidovici, N. Sattar, J.C. Prinz, L. Puig, P. Emery, J.N. Barker, et al.
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
J Invest Dermatol, 130 (2010), pp. 1785-1796
[50.]
M.C. Saenz-Santamaria, F.J. Garcia-Latasa, Y. Gilaberte, F.J. Carapeto.
Dermatologic diseases in Don Quixote: skin conditions from Cervantes’ pen.
Int J Dermatol, 34 (1995), pp. 212-215
Copyright © 2011. Asociación Española de Dietistas-Nutricionistas
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos